Biopharmaceutical Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Biopharmaceutical market
Biopharmaceutical Market: By Source (Unicellular & Multicellular Systems) By Products (Vaccines, Enzymes, Others) Manufacturing Process (Single & Multi Use Systems) Application (Oncology, Cardiology, Others) End Users (Hospitals, Others) & Geography - Forecast(2018 - 2023)
Report Code : HCR 0054
Updated Date: 25 October, 2018  
5

Copies sold

    Client Rating

1. Biopharmaceutical Market - Overview
1.1. Definitions and Scope
2. Biopharmaceutical Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Biopharmaceutical Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Biopharmaceutical Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Biopharmaceutical Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Biopharmaceutical Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Biopharmaceutical Market - Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Biopharmaceutical Market – By Source (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Unicellular System
8.3.1.1. Bacteria
8.3.1.2. Yeast
8.3.1.3. Insect
8.3.2. Multicellular System
8.3.2.1. Transgenic Plant
8.3.2.2. Transgenic Animal
9. Biopharmaceutical Market – By Products (Market Size -$Million / $Billion)
9.1. Vaccines
9.2. Hormones
9.3. Enzymes
9.4. Blood
9.5. Blood Components
9.6. Monoclonal Antibodies
9.7. Growth Factors
9.8. Gene Therapies
9.9. Thrombolytics and Anticoagulants
9.10. Recombinant Therapeutic Protein
10. Biopharmaceutical Market – By Manufacturing Process (Market Size -$Million / $Billion)
10.1. Single-Use System
10.2. Multi- Use System
11. Biopharmaceutical Market – By Application (Market Size -$Million / $Billion)
11.1. Rheumatology
11.2. Oncology
11.3. Cardiology
11.4. Dermatology
11.5. Gastroenterology
11.6. Neurology
11.7. Others
12. Biopharmaceutical – By End Use Industry(Market Size -$Million / $Billion)
12.1. Segment type Size and Market Share Analysis 
12.2. Application Revenue and Trends by type of Application
12.3. Application Segment Analysis by Type
12.3.1. Biopharmaceutical Companies
12.3.2. Hospitals
12.3.3. Research Institutes
12.3.4. CROs
12.3.5. Diagnostic Labs
13. Biopharmaceutical - By Geography (Market Size -$Million / $Billion)
13.1. Biopharmaceutical Market - North America Segment Research
13.2. North America Market Research (Million / $Billion)
13.2.1. Segment type Size and Market Size Analysis 
13.2.2. Revenue and Trends
13.2.3. Application Revenue and Trends by type of Application
13.2.4. Company Revenue and Product Analysis
13.2.5. North America Product type and Application Market Size
13.2.5.1. U.S.
13.2.5.2. Canada 
13.2.5.3. Mexico 
13.2.5.4. Rest of North America
13.3. Biopharmaceutical - South America Segment Research
13.4. South America Market Research (Market Size -$Million / $Billion)
13.4.1. Segment type Size and Market Size Analysis 
13.4.2. Revenue and Trends
13.4.3. Application Revenue and Trends by type of Application
13.4.4. Company Revenue and Product Analysis
13.4.5. South America Product type and Application Market Size
13.4.5.1. Brazil  
13.4.5.2. Venezuela
13.4.5.3. Argentina
13.4.5.4. Ecuador
13.4.5.5. Peru
13.4.5.6. Colombia 
13.4.5.7. Costa Rica
13.4.5.8. Rest of South America
13.5. Biopharmaceutical - Europe Segment Research
13.6. Europe Market Research (Market Size -$Million / $Billion)
13.6.1. Segment type Size and Market Size Analysis 
13.6.2. Revenue and Trends
13.6.3. Application Revenue and Trends by type of Application
13.6.4. Company Revenue and Product Analysis
13.6.5. Europe Segment Product type and Application Market Size
13.6.5.1. U.K  
13.6.5.2. Germany 
13.6.5.3. Italy 
13.6.5.4. France
13.6.5.5. Netherlands
13.6.5.6. Belgium
13.6.5.7. Spain
13.6.5.8. Denmark
13.6.5.9. Rest of Europe
13.7. Biopharmaceutical – APAC Segment Research
13.8. APAC Market Research (Market Size -$Million / $Billion)
13.8.1. Segment type Size and Market Size Analysis 
13.8.2. Revenue and Trends
13.8.3. Application Revenue and Trends by type of Application
13.8.4. Company Revenue and Product Analysis
13.8.5. APAC Segment – Product type and Application Market Size
13.8.5.1. China 
13.8.5.2. Australia
13.8.5.3. Japan 
13.8.5.4. South Korea
13.8.5.5. India
13.8.5.6. Taiwan
13.8.5.7. Malaysia
14. Biopharmaceutical Market - Entropy
16.1. New product launches
16.2. M&A's, collaborations, JVs and partnerships
15. Biopharmaceutical Market – Industry / Segment Competition landscape
15.1. Market Share Analysis
15.1.1. Market Share by Country- Top companies
15.1.2. Market Share by Region- Top 10 companies
15.1.3. Market Share by type of Application – Top 10 companies
15.1.4. Market Share by type of Product / Product category- Top 10 companies
15.1.5. Market Share at global level- Top 10 companies
15.1.6. Best Practises for companies
16. Biopharmaceutical Market – Key Company List by Country
17. Biopharmaceutical Market Company Analysis
17.1. Market Share, Company Revenue, Products, M&A, Developments
17.2. Roche Holding AG
17.3. Abbott Laboratories
17.4. Bristol-Myers Squibb
17.5. Novartis International AG
17.6. Genentech Inc.
17.7. UCB
17.8. Merck Serono
17.9. Amgen
17.10. Eli Lilly & Co.
17.11. Biogen Idec
17.12. Merck KGaA
17.13. Élan Corporation
17.14. BioMarin Pharmaceutical Inc.
17.15. AbbVie Inc.
17.16. Invion Limited
17.17. AdAlta Pty Ltd.
17.18. Admedus Ltd
17.19. Biota Pharmaceuticals Inc.
17.20. Novozymes
17.21. Baxter International
17.22. APEIRON Biologics AG
17.23. Octapharma AG
17.24. Valneva SE
17.25. Genzyme
17.26. Mallinckrodt Pharmaceuticals
17.27. TM3 Therapeutics
"*Financials would be provided on a best efforts basis for private companies"
18. Biopharmaceutical Market - Appendix
18.1. Abbreviations
18.2. Sources
19. Biopharmaceutical Market - Methodology
19.1. Research Methodology
19.1.1. Company Expert Interviews
19.1.2. Industry Databases
19.1.3. Associations
19.1.4. Company News
19.1.5. Company Annual Reports
19.1.6. Application Trends
19.1.7. New Products and Product database
19.1.8. Company Transcripts
19.1.9. R&D Trends
19.1.10. Key Opinion Leaders Interviews
19.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll